Cargando…
Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer
(1) Background: There are currently limited treatments for castration-resistant prostate cancer. Immunotherapy involving Sipuleucel-T has increasingly drawn attention for prostate cancer management. BCG plays a vital role in treating bladder cancer, mainly by inducing immune activation, but is rarel...
Autores principales: | Guo, Linpei, Xie, Hui, Zhang, Zheng, Wang, Zhun, Peng, Shuanghe, Niu, Yuanjie, Shang, Zhiqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310044/ https://www.ncbi.nlm.nih.gov/pubmed/34358202 http://dx.doi.org/10.3390/vaccines9070786 |
Ejemplares similares
-
Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2018) -
Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer
por: Xie, Hui, et al.
Publicado: (2022) -
YAP is required for prostate development, regeneration, and prostate stem cell function
por: Xie, Hui, et al.
Publicado: (2023) -
Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals
por: Wang, Zhun, et al.
Publicado: (2017) -
Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2017)